Enter Discount Code 10HEALTHY at checkout for $10 off orders of $100 or more! Brand exclusions apply - Click for details
Mucolyxir® is a liquid nutritional supplement, formulated from doublestranded deoxyribonucleic acid (DNA) derived from wild Pacific salmon. The small amount of DNA in Mucolyxir® may balance mucus levels via a regulatory mechanism. Based on pre-clinical investigations and clinical trials, Mucolyxir® appears to support cilia motion, and liquification and elimination of mucoid substance.
| Serving Size: 1 Drop (0.05 ml) | Amount/Serving |
| DNA (from Salmon) | 0.3 µg |
Other Ingredients: Deionized water, glycerin, sodium chloride, lactic acid, potassium sorbate.
As a dietary supplement, 1 or 2 drops, placed in mouth slowly, then swallowed, one to four times per day, or as directed by a healthcare practitioner. To avoid dilution, do not eat or drink for 5 minutes after taking.
First time use: To get liquid flowing, follow this one-time procedure. With uncapped bottle upright, carefully pull out plastic insert from top of bottle, and then replace it
securely.
Additional Usage Notes: At the start of use, individuals may take more, as follows:
Day 1: Take 1 drop every fifteen minutes for one hour. Then take 1 drop every hour until bedtime.
Days 2 and 3: Take 1 drop after each meal and before bed (4 times total).
Day 4 and beyond: Maintain schedule or use only as needed.
Warning: Some individuals may experience increased mucus excretion with only 1 or 2 doses.
It is thought that the viscous sputum that occludes airways may be partially the result of accumulated DNA. This excess DNA gathers in part from the activity of the immune system, as it tries to eliminate bacteria from the lungs. Mucolyxir® appears to work by providing a feedback mechanism that reestablishes homeostasis relative to the various components of the immune response. This more balanced response can result in a more fluid (less viscous) sputum, enhancing the natural eliminatory activity of the body.
The viscosity of mucus may be partially attributed to excessive DNA resulting from a build-up of lysed white blood cells from the body’s failed attempt to eliminate foreign material. DNA in bacteria can induce interleukin-8 (IL-8), which in turn promotes release of phagocytic cells that can destroy the bacteria. But if the lungs are unable to eliminate the DNA residues of this immune activity, then the airways can become congested. The immune response becomes partially a compensatory mechanism for the body’s failure to eliminate the DNA build-up through the normal process of expectoration. As the phagocytes continue to work, phagocytic DNA is added to that from the bacteria. This combined accumulation of DNA also augments the likelihood that the immune system will become increasingly sensitized to DNA. The result is that the natural power of the immune response gets directed into a cycle of increasing ineffectiveness, as its own activity creates conditions that call for more immune response.
The small amount of DNA in Mucolyxir® may balance mucus levels via a neutralization or feedback mechanism, just as a small amount of ragweed extract is used to down regulate or balance immune response to environmental factors. Mucolyxir® appears to interrupt the DNA build-up cycle by helping to reduce the excess production of IL-8, decreasing the intensity of phagocytic activity while simultaneously increasing its effectiveness.
